Today: 19 July 2026
CapitaLand Investment share price: What 9CI holders watch after director filings, ahead of Feb 11 results
1 February 2026
1 min read

CapitaLand Investment share price: What 9CI holders watch after director filings, ahead of Feb 11 results

Singapore, Feb 1, 2026, 15:06 SGT — Market closed.

  • CapitaLand Investment ended the day unchanged, closing at S$3.08.
  • Filings late in the week revealed shifts in director interests related to treasury share transfers.
  • CapitaLand Ascott Trust, a major managed trust, released its FY2025 distribution figures as earnings season kicks off.

CapitaLand Investment shares closed flat on Friday at S$3.08, fluctuating within a range of S$3.05 to S$3.10. The stock traded roughly 13 million shares.

As the Singapore market remains closed for the weekend, attention turns to the upcoming wave of full-year results and distribution announcements from CapitaLand-managed listed vehicles, followed by the manager’s own earnings. This stretch could shift expectations around fee income and capital recycling, even if the parent company’s stock stays muted.

Friday brought a wave of board-related disclosures. On their own, these filings rarely shift a stock, but they can stir up some noise when liquidity is light.

David Su Tuong Sing disclosed buying 25,009 shares on Jan. 28 at S$2.543 each, acquiring them through a transfer of treasury shares. This raised his direct stake from 55,241 to 80,250 shares. Treasury shares refer to stock a company holds post-buyback and can be allocated for share-based payments without issuing fresh shares.

CapitaLand Ascott Trust, managed by subsidiaries of CapitaLand Investment, reported on Thursday. The trust held its full-year distribution per stapled security (DPS) steady at 6.10 Singapore cents, even as income available for distribution climbed 11% to S$256.7 million. Serena Teo noted, “We are progressing towards our medium-term portfolio allocation of 25%–30% in the living sector.” Lui Chong Chee added, “Looking ahead, we are focused on delivering sustainable growth and long-term value for our Stapled Securityholders.” The trust confirmed that stapled securityholders will receive their second-half payout on Feb. 27. SGX Links

CapitaLand Investment outlined a busy schedule of earnings announcements in a Singapore Exchange notice, with results from its listed funds rolling out before its FY2025 report on Feb. 11, ahead of market open. The lineup starts with CapitaLand India Trust on Feb. 2, followed by CapitaLand China Trust and CapitaLand Ascendas REIT on Feb. 5, and then CapitaLand Integrated Commercial Trust on Feb. 6.

The filing noted that CapitaLand Investment plans a results briefing at 9 a.m. on the day it reports earnings, open to invited analysts and media. There will be a “live” webcast available. SGX Links

CapitaLand Investment manages real assets and collects fees from overseeing listed property trusts and private funds. Morningstar reports its total assets under management stood at SGD 117 billion as of June 30, 2025.

The downside risk is straightforward. If upcoming results reveal weaker asset values, sluggish asset sales, or faltering performance in key portfolios, fee forecasts could quickly be revised downward — and real estate managers often react sharply to that.

Next up, all eyes will be on Monday’s CapitaLand India Trust figures, followed by CapitaLand Investment’s FY2025 results scheduled for Feb. 11.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • CSL Recovers A$16 Billion in Value, Trails Plasma Sector Gains This Week
    July 19, 2026, 3:25 PM EDT. CSL Limited (ASX:CSL) finished July 17 at A$123.32, rising 1.12% on the session and 0.35% for the week, recovering 37% from its 52-week low at A$90 and regaining roughly A$16 billion in valuation. However, CSL underperformed plasma specialists Grifols SA (+1.95%) and Takeda Pharmaceutical (+2.26%) in weekly movement. Trading volume for CSL on Friday came in 14% under its average as 1.62 million shares changed hands. The full-year financial results are due August 18. Still 55% beneath its 52-week peak, CSL's market value stands at A$59.06 billion. The group forecasts FY26 revenues near US$15.2 billion and NPATA of about US$3.1 billion, while a US$5 billion impairment remains subject to audit and board sign-off.
Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB
Previous Story

Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB

BAT share price: British American Tobacco stock heads into Monday with lawsuit cloud and results clock ticking
Next Story

BAT share price: British American Tobacco stock heads into Monday with lawsuit cloud and results clock ticking

Go toTop